The concern is that vaccines will target the site that is mutated in the South African variant.
Looked at the BioRxiv preprint that warns of this variant (
here) and it appears to be at amino acid 484, located in a region called the receptor binding domain, or RBD of the spike protein. The mutation is from a glutamic acid residue mutated to lysine, though nobody knows how this affects virulence. From numerous prior studies, it's pretty well established that the RBD region is one of the most common targets of "natural" immune neutralization seen in most people who are infected with SARS CoV2, and preprint describes that the South African mutation allows for escape from neutralizing antibodies and T-cell response.
The mRNA vaccines prevalent in the US (Pfizer and Moderna) basically provide a dummy spike protein as target practice for the immune system (summarized
here and also discusses the RBD), and would therefore likely elicit a similar response targeting the RBD.
So TL;DR: yes, my understanding is that the South African variant is worrisome in that it might allow for escape from the current mRNA vaccines used in the USA.
Of course, Pfizer and/or Moderna could (and probably will, if the situation gets dire enough) just rejigger the mRNA target to take the variant into account, but that would require re-immunizing everyone.
Would love to hear mofro's thoughts on the matter.